Pfm Health Sciences, LP Heron Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $8.08 Million - $22.1 Million	-3,512,348 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $4.33 Million - $6.54 Million	518,802 Added 17.33%	3,512,348 $32.1 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $8.05 Million - $11.9 Million	794,489 Added 36.13%	2,993,546 $32 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $1.33 Million - $1.86 Million	100,479 Added 4.79%	2,199,057 $34.1 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $1.26 Million - $1.8 Million	87,101 Added 4.33%	2,098,578 $34 Million
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $2.04 Million - $3.09 Million	139,465 Added 7.45%	2,011,477 $42.6 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $4.91 Million - $6.39 Million	-359,390 Reduced 16.11%	1,872,012 $27.7 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $2.73 Million - $5.38 Million	-250,515 Reduced 10.09%	2,231,402 $32.8 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $25.4 Million - $61 Million	2,481,917 New	2,481,917 $29.1 Million

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.